US2012302638A1PendingUtilityA1
Esters of 4,5-disubstituted-oxy-2-methyl-3,6-dioxo-cyclohexa-1,4-dienyl alkyl acids and preparation thereof
Est. expirySep 23, 2028(~2.2 yrs left)· nominal 20-yr term from priority
A61P 29/00A61K 31/22A61P 17/00C07C 67/08C07C 69/95A61K 31/23C07C 2601/16
44
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Esters of 4,5-disubstituted-oxy-2-methyl-3,6-dioxo-cyclohexa-1,4-dienyl alkyl acids were prepared chemically and/or enzymatically. Depending upon the ester, improved melanocyte cytotoxicity was achieved. Improved cytotoxicity characteristics are consistent with ester analogs being more physiologically compatible and less irritating to skin than their corresponding acids.
Claims
exact text as granted — not AI-modified1 . A process for preparing an ester comprising:
a) reacting an acid, anhydride, or acid derivative of formula 2
wherein X is —OH, —SH, —F, —Cl, —Br, —I, or —OR 3 ; and R and R 1 are each independently a C 1 -C 4 alkyl; and n is 2-18; and
wherein R 3 is C 1 -C 6 -alkyl or substituted C 1 -C 6 -alkyl.
with an alcohol of formula 3:
wherein R 4 , R 5 , and R 6 are each an aliphatic hydrocarbons containing from about 6 to about 22 carbons
in the presence of an organic solvent to form at least on ester; and
b) isolating said at least one ester.
2 . The process according to claim 1 , wherein the solvent is diethyl ether, diisopropyl ether, tert-butyl methyl ether, tetrahydrofuran, benzene, toluene, xylene, hexane, heptane, cyclohexane, or limonene, dichloromethane, dichloroethane, dibromoethane, tetrachloroethylene, chlorobenzene, acetonitrile, dimethyl formamide, dimethyl sulfoxide, or mixtures thereof.
3 . The process according to claim 1 , wherein the reacting occurs at a temperature of between about −100° C. and a boiling point of the solvent.
4 . The process according to claim 3 , wherein the temperature is between about 0° C. and about 60° C.
5 . The process according to claim 4 , wherein the temperature is between about 20° C. and about 50° C.
6 . The method according to claim 1 , wherein step a) further comprises being in the presence of an enzyme.
7 . The method according to claim 6 , wherein, the enzyme is a protease, a lipase, or an esterase.
8 . A method for treating a skin condition comprising applying an effective amount of a composition, comprising an ester and a dermatologically acceptable carrier, wherein the ester is represented by the general formula 1:
wherein R and R 1 are each independently a C 1 -C 4 alkyl, R 2 is a C 6 -C 22 alkyl, C 6 -C 22 alkenyl, C 6 -C 20 dienyl, C 6 -C 22 trienyl, C 8 -C 22 tetraenyl or a mixture thereof, and n is 2-18.
9 . The method according to claim 8 , wherein said skin condition is selected from the group consisting of skin roughness, skin wrinkles, photodamaged skin, skin hyperpigmentation, skin irritation, and skin inflammatory reaction.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.